| X23-10-ZQ354 |
Bcr-Abl inhibitor AT9283, Purity ≥98%
|
|
| X24-06-ZQ320 |
Bcr-Abl inhibitor 1-Naphthyl PP1 hydrochloride, Purity ≥98%
|
|
| X24-06-ZQ326 |
Bcr-Abl inhibitor AZD0424, Purity ≥98%
|
|
| X24-06-ZQ331 |
Bcr-Abl inhibitor BMS-354825, Purity ≥98%
|
|
| X24-06-ZQ342 |
Bcr-Abl inhibitor Lyn-IN-1, Purity ≥98%
|
|
| X24-06-ZQ350 |
Bcr-Abl inhibitor AZD0530, Purity ≥98%
|
|
| X24-06-ZQ365 |
Bcr-Abl inhibitor CHMFL-ABL/KIT-155, Purity ≥98%
|
|
| X24-06-ZQ367 |
Bcr-Abl inhibitor Dasatinib monohydrate, Purity ≥98%
|
|
| X24-06-ZQ416 |
Bcr-Abl inhibitor Asciminib, Purity ≥98%
|
|
| X24-06-ZQ419 |
Bcr-Abl inhibitor INNO-406, Purity ≥98%
|
|
| X24-06-ZQ423 |
Bcr-Abl inhibitor BCR-ABL-IN-1, Purity ≥98%
|
|
| X24-06-ZQ424 |
Bcr-Abl inhibitor BCR-ABL-IN-2, Purity ≥98%
|
|
| X24-06-ZQ437 |
Bcr-Abl inhibitor CHMFL-ABL-039, Purity ≥98%
|
|
| X24-06-ZQ438 |
Bcr-Abl inhibitor CHMFL-ABL-121, Purity ≥98%
|
|
| X24-06-ZQ441 |
Bcr-Abl inhibitor CT-721, Purity ≥98%
|
|
| X24-06-ZQ442 |
Bcr-Abl inhibitor CZC-8004, Purity ≥98%
|
|
| X24-06-ZQ444 |
Bcr-Abl inhibitor DCC-2036, Purity ≥98%
|
|
| X24-06-ZQ447 |
Bcr-Abl inhibitor DPH, Purity ≥98%
|
|
| X24-06-ZQ460 |
Bcr-Abl inhibitor GNF 2, Purity ≥98%
|
|
| X24-06-ZQ461 |
Bcr-Abl inhibitor GNF 5, Purity ≥98%
|
|
